The insider selling at around the current share price of US$80.90 is a cause for slight concern. The lack of insider purchases in the last year, despite significant insider ownership, does not inspire confidence in the company.
Efficient markets hypothesis implies markets are over-reactive and investors may not always be rational. The firm's higher EPS growth versus its annual share price increment indicates a potential surge in market caution towards the stock.
Insider trading at Pinnacle Financial Partners suggests a bearish signal as there's been more selling than buying in the past year. While strong insider ownership is seen as positive, extensive share selling warrants closer inspection.
Upgrades •$Allegiance(ABTX.US)$: Raymond James Upgrades to Outperform from Market Perform - PT $43 •$ブンゲ(BG.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $106 (from $130) •$セレンス(CRNC.US)$: RBC Capital Upgrades to Sector Perform from Underperform - PT $27 (from $28) •$ファースト ミッド バンクシェアーズ(FMBH.US)$: Raymond James Upgrades to Outperform from Market Perform - PT $45 •$ラマー・アドバタイジング(LAMR.US)$: Citigroup Up...
Gainers: •$Checkmate Pharmaceuticals(CMPI.US)$+331.5% (Regeneron Pharma (REGN) to acquire CMPI for $10.50/share in cash) •$アクサム セラピューティクス(AXSM.US)$+27.9% (received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the New Drug Application for its AXS-05 product candidate for the treatment of major depressive disorder) •$スーパー マイクロ コンピューター(SMCI.US)$+14.3% (earnings report) •$プラグ パワー(PLUG.US)$+9.24% (t...
ピナクル ファイナンシャル パートナーズに関するコメント
• $Allegiance(ABTX.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $43
• $ブンゲ(BG.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $106 (from $130)
• $セレンス(CRNC.US)$ : RBC Capital Upgrades to Sector Perform from Underperform - PT $27 (from $28)
• $ファースト ミッド バンクシェアーズ(FMBH.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $45
• $ラマー・アドバタイジング(LAMR.US)$ : Citigroup Up...
• $Checkmate Pharmaceuticals(CMPI.US)$ +331.5% (Regeneron Pharma (REGN) to acquire CMPI for $10.50/share in cash)
• $アクサム セラピューティクス(AXSM.US)$ +27.9% (received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the New Drug Application for its AXS-05 product candidate for the treatment of major depressive disorder)
• $スーパー マイクロ コンピューター(SMCI.US)$ +14.3% (earnings report)
• $プラグ パワー(PLUG.US)$ +9.24% (t...
finally close at all time high
まだコメントはありません